Jerzy Hołowiecki

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

Oliver A. Cornely, Johan Maertens, Drew J. Winston et al. · New England Journal of Medicine · 2007 · 1.8K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

Craig H. Moskowitz, Auayporn Nademanee, Tamás Masszi et al. · The Lancet · 2015 · 734 citations · Full text

Medicine, Immunology, Oncology +15

Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study

Bertrand Coiffier, Stéphane Leprêtre, Lars Møller Pedersen et al. · Blood · 2007 · 385 citations

Medicine, Hematology, Oncology +16

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial

Hagop Kantarjian, Ricardo Pasqüini, Nelson Hamerschlak et al. · Blood · 2007 · 378 citations · Full text

Medicine, Hematology, Oncology +5

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

Heinz Gisslinger, Mirjana Gotić, Jerzy Hołowiecki et al. · Blood · 2013 · 322 citations · Full text

Medicine, Hematology, Pharmacology +5